U.S. markets open in 5 hours 9 minutes

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.86+0.36 (+1.36%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/6/2021
Current
12/31/2020
Market Cap (intraday) 5
1.51B1.67B
Enterprise Value 3
1.13B1.67B
Trailing P/E
N/AN/A
Forward P/E 1
N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
N/AN/A
Price/Book (mrq)
3.24N/A
Enterprise Value/Revenue 3
N/AN/A
Enterprise Value/EBITDA 7
-13.44-50.74

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-2.11%
S&P500 52-Week Change 344.55%
52 Week High 339.60
52 Week Low 319.60
50-Day Moving Average 326.15
200-Day Moving Average 329.40

Share Statistics

Avg Vol (3 month) 3211.53k
Avg Vol (10 day) 3126.14k
Shares Outstanding 556.07M
Implied Shares Outstanding 6N/A
Float 43.04M
% Held by Insiders 113.30%
% Held by Institutions 162.19%
Shares Short (Apr 14, 2021) 43.92M
Short Ratio (Apr 14, 2021) 412.38
Short % of Float (Apr 14, 2021) 49.96%
Short % of Shares Outstanding (Apr 14, 2021) 46.99%
Shares Short (prior month Mar 14, 2021) 42.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.80%
Return on Equity (ttm)-31.30%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -57.2M
Net Income Avi to Common (ttm)-88.44M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)413.06M
Total Cash Per Share (mrq)7.37
Total Debt (mrq)32.06M
Total Debt/Equity (mrq)6.89
Current Ratio (mrq)32.65
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-37.91M
Levered Free Cash Flow (ttm)-35.88M